LITHIUM-INDUCED NEPHROGENIC DIABETES INSIPIDUS RESPONSIVE TO DESMOPRESSIN

dc.contributor.authorTaşçı, Elif Şenocak
dc.contributor.authorErap, H.
dc.contributor.authorKayataş, K.
dc.date.accessioned2020-04-30T23:18:57Z
dc.date.available2020-04-30T23:18:57Z
dc.date.issued2019
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionWOS: 000485206400020en_US
dc.descriptionPubMed: 31508188en_US
dc.description.abstractNephrogenic diabetes insipidus (NDI) is the most common renal side effect seen with lithium therapy. Persisting cases after the cessation of the therapy may be seen when lithium therapy is continued for too long. Although desmopressin treatment is not one of the accepted treatment modalities for NDI, there are few reports using desmopressin treatment in unresponsive cases. Herein, we reported the fourth lithium-induced NDI case in the literature responsive to desmopressin therapy.en_US
dc.identifier.doi10.4183/aeb.2019.270en_US
dc.identifier.endpage271en_US
dc.identifier.issn1841-0987
dc.identifier.issn1843-066X
dc.identifier.issue2en_US
dc.identifier.startpage270en_US
dc.identifier.urihttps://doi.org/10.4183/aeb.2019.270
dc.identifier.urihttps://hdl.handle.net/20.500.12684/3592
dc.identifier.volume15en_US
dc.identifier.wosWOS:000485206400020en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherEditura Acad Romaneen_US
dc.relation.ispartofActa Endocrinologica-Bucharesten_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectdesmopressinen_US
dc.subjectdiabetes insipidusen_US
dc.subjectlithiumen_US
dc.subjectnephrogenicen_US
dc.titleLITHIUM-INDUCED NEPHROGENIC DIABETES INSIPIDUS RESPONSIVE TO DESMOPRESSINen_US
dc.typeLetteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
3592.pdf
Boyut:
201.89 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text